alpha-D-Xylf-(1->3)-alpha-D-Xylf-(1->3)-D-Glcp

Term ID

CHEBI:148667

Synonyms

(3R,4S,5R,6R)-4-[(2R,3R,4R,5R)-4-[(2R,3R,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-6-(hydroxymethyl)oxane-2,3,5-triol
alpha-D-xylo-pentofuranosyl-(1->3)-alpha-D-xylo-pentofuranosyl-(1->3)-D-gluco-hexopyranose
alpha-D-xylofuranosyl-(1->3)-alpha-D-xylofuranosyl-(1->3)-D-glucopyranose
WURCS=2.0/2,3,2/[a2122h-1x_1-5][a212h-1a_1-4]/1-2-2/a3-b1_b3-c1
Xylf(a1-3)Xylf(a1-3)Glc

Definition

A trisaccharide consisting of two alpha-D-xylofuranose residues and a D-glucopyranose residue joined in sequence by two (1->3) glycosidic bonds.

References

Ontology

ChEBI ( EBI )

Relationships

Phenotype

Phenotype resulting from alpha-D-Xylf-(1->3)-alpha-D-Xylf-(1->3)-D-Glcp

Phenotype where environments contain alpha-D-Xylf-(1->3)-alpha-D-Xylf-(1->3)-D-Glcp

Phenotype modified by environments containing alpha-D-Xylf-(1->3)-alpha-D-Xylf-(1->3)-D-Glcp

Human Disease Model